PharmTech Talk

Oct 27, 2015
Despite considerable investment by biotech manufacturers in developing competitive biologics for the US market, gaining FDA approval of these products has turned out to be a slow and complex process.
Oct 13, 2015
By Pharmaceutical Technology Editors
A CPhI report predicts how two potential mega free-trade deals, one among Pacific-Rim countries and the other between the US and EU, could affect pharmaceutical companies.
Oct 13, 2015
By Pharmaceutical Technology Editors
A CPhI report suggests that the pharma industry should be careful not to outsource to lower labor-cost countries rather than investing in manufacturing technology and innovation.
Oct 02, 2015
Pharmaceutical Technology
In the development of biopharmaceuticals and pharmaceuticals, the line is blurring.
Sep 24, 2015
Although the presidential candidate seeks to cap monthly drug costs to $250 for covered drugs, what will happen to drug costs that are associated with co-insurance?
Sep 22, 2015
In testifying before Congress on FDA regulation of long-awaited biosimilars, Janet Woodcock emphasized the importance of ensuring that the evaluation of new therapies is based on sound science.
Sep 18, 2015
By Pharmaceutical Technology Editors
CPhI expert, Girish Malhotra, warns that without urgent regulatory reform, the industry would remain reluctant to make process changes that will improve manufacturing efficiency due to the financial and time constraints of re-approval.
Sep 16, 2015
The White House nominates Robert Califf to head FDA, but will he be confirmed?
Sep 02, 2015
Worldwide, meetings take place for several reasons, such as to share new findings, learn about novel technologies, discuss international issues, exchange know-hows, and network, to name a few. While each of these reasons has its significant importance, what really matters in scientific inquiry is progress.
Aug 24, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
Manufacturers seek gradual rollout of more targeted FDA quality metrics program.
lorem ipsum